In a previous pilot randomized trial, we showed that a new integrated airway system (AnapoGuard-100 ET and control unit) was safe and effective in terms of cuff pressure control and subglottic secretions evacuation, with a strong trend in reducing microbiologically confirmed VAP [ 5 ].
← all excerpts
Use of an innovative cuff pressure control and subglottic secretions drainage system in COVID-19 ARDS patients undergoing pronation.
1
—
—